How To Use Progressive Web App aka PWA On 420 Magazine Forum
Note: This feature may not be available in some browsers.
I wonder if the decreasing light would also increase the chance of nanners in order to propagate it self before it dies.
Brick top, I personally go by results. In most all cases, indoor grown weed under 12/12 for flowering is more potent.
Of course, there are many other factors that contribute to that, but so far, I haven't seen diminished light indoors result in higher potent weed.
I don't go by what people write. I go by results, personally. Been growing three years and always experimenting. By results, I mean what majority say about the strength of the end result from the dispensary.
I don't put much faith in the testing for THC percent. I put one strain of Afgoo in the dispensary, which tested at 28% THC, but didn't get people nearly as high as a strain of Critical 47 I grew, which tested at 21% THC.
Both had a CBD of .1
After the mandatory testing began this year, almost every strain at the dispensaries are between 21-28% THC with .1 CBD. At least half test 25% or higher. Yet, the quality is clearly not the same based on consumer/patient reports.
I am going to have the exact same crop from the exact same plant tested multiple times just to see if I get different results. I will use different labs. I predict I will get different percent of THC from each test.
My main point here is, we cannot rely on lab results to see if something change in lighting or humidity, curing process, etc made our weed stronger. The best testing to do for that right now, I believe is blind tests. Don't let the people know what they are smoking and have them grade it from 1-10 in how high it gets them.
Be sure to have the same people come back for multiple tests of the same strains just to see how much their answers differ. Based on other blind tests, I am sure the same person will grade the same strain with slightly different numbers. He/she is also not allowed to smell or see the product they are smoking.
Now if I can take a batch in from the same plant and have it tested multiple times by different labs and get pretty much the same results, I will at least be less skeptical. However, even with consistent lab results, it seems different people react differently to different strains.
I know I for one, will get drunk easier on a 40 proof whiskey than a 40 proof vodka. Something else other than the percent of alcohol affects me differently.
So in conclusion, what really matters is how effective the medicine is for the patients. If majority of the patients say this strain is weak, then it doesn't matter what the lab results say, and yes, I have had that happen multiple times. Lab results were great; patients thought it was okay.
Project CBD > Medicine > Science
Science
Lab notesCannabis has been at the center of one of the most exciting — and underreported — developments in modern science. Research on marijuana's effects led directly to the discovery of a hitherto unknown biochemical communication system in the human body, the Endocannabinoid System, which plays a crucial role in regulating our physiology, mood, and everyday experience.
The discovery of receptors in the brain that respond pharmacologically to cannabis — and the subsequent identification of endogenous cannabinoid compounds in our own bodies that bind to these receptors — has significantly advanced our understanding of human biology, health, and disease.
It is an established scientific fact that cannabinoids and other components of cannabis can modulate many physiological systems in the human brain and body. Cannabinoids are chemical compounds that trigger cannabinoid (and other) receptors. More than 100 cannabinoids have been identified in the marijuana plant. Of these, tetrahydrocannabinol (THC) and cannabidiol (CBD) have been studied most extensively. In addition to cannabinoids produced by the plant, there are endogenous cannabinoids (anandamide and 2AG) that occur naturally in the body, as well as synthetic cannabinoids created by pharmaceutical researchers.
Extensive preclinical research — much of it sponsored by the U.S. government — indicates that CBD has potent anti-tumoral, antioxidant, anti-spasmodic, anti-psychotic, anti-convulsive, and neuroprotective properties. CBD directly activates serotonin receptors, causing an anti-depressant effect, as well.
In recent years, scientists associated with the International Cannabinoid Research Society (ICRS) have elucidated a number of molecular pathways whereby CBD exerts a therapeutic impact. A preclinical study by Dr. Sean McAllister and his colleagues at the California Pacific Medical Center in San Francisco reports on how CBD kills breast cancer by down-regulating a gene called ID-1, which is implicated in several types of aggressive cancer. Silencing the ID-1 gene is thus is an excellent strategy for a cancer treatment.
"Cannabidiol offers hope of a non-toxic therapy that could treat aggressive forms of cancer without any of the painful side effects of chemotherapy," says McAllister.
CBD and breast cancer
The images above are from an experiment by McAllister testing how CBD can stop the invasion of cancer cells in human cell lines. Compare the untreated breast cancer cells on the left to the breast cancer cells destroyed by CBD on the right.
Clinical studies conducted outside the United States have shown that CBD is an effective painkiller — particularly for peripheral neuropathy associated with cancer, multiple sclerosis, diabetes, arthritis, and other neurodegenerative conditions.
Sativex, a whole plant cannabis extract with equal levels of CBD and THC, is an under-the-tongue spray produced by GW Pharmaceuticals, a British company. Administered in repeatable, measurable doses, Sativex is clinically effective without causing psychoactivity. It has been officially approved as a medication for neuropathic pain in Great Britain, Canada, and more than 20 other countries. It is currently undergoing phase III clinical trials in the United States.
GW scientists determined that CBD is most effective therapeutically when administered in combination with whole plant THC. Cannabidiol interacts synergistically with THC. CBD enhances THC's painkilling impact, while muting THC's psychoactivity. CBD can also neutralize unfavorable effects that THC may cause, such as anxiety and rapid heartbeat.
Some one suggested to me that I put my plants on 16/16 because they are in a greenhouse.
Thought there could be some gettin at nite so I fixed the canopy and realized what 16 and 16 would require.
Any thoughts guys ....
Brick top, I never said I put a low value on CBD. I only said that at dispensaries, most all strains have low CBDs. .1 usually. A few have 2.2, and a few rare ones have 6-12% like Ak-48, but I wonder how accurate those are.
I think a lot of science is pretty accurate, like physics. When lab results show steady predictable numbers, I will take such studies of diminished light more seriously.
I also never said for people to trust me. They should do their own experiments, as I will continue to do mine. It's not like I have given up on diminished light. I will run tests again.
Once I have grown my new strains enough to be able to predict the weight I will get from them in my grow room, then I will try diminished light again to see if quality or weight increases. But, the ultimate test for me is my patience. If the majority of them don't notice a difference then all I care about is if it increases yield.
Honestly, no lab results or scientific data matters when it comes to quality if the majority of people don't think it helps them more.
It would be like if scientists could prove that raw coco gives you more energy than caffeine, yet the majority of people experience more energy on caffeine. At that point, who cares what science says. Caffeine wins in the eyes of the people.